Lucia Catani
0000-0002-4650-201X
110 papers found
Refreshing results…
Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms
Circulating CD4+CD25-Foxp3+ cells are increased in patients with Immune Thrombocytopenia
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis
MYH9-related thrombocytopenia and intracranial bleedings: a complex clinical/surgical management and review of the literature
Ruxolitinib-associated tuberculosis: a case of successful ruxolitinib rechallenge
The choice of second‐line therapy in steroid‐resistant immune thrombocytopenia: Role of platelet kinetics in a single‐centre long‐term study
Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis
Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: Possible role of MPL polymorphisms
Victims at the International Criminal Court: Some Lessons Learned from the Lubanga Case
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia
Very elderly patients with essential thrombocythaemia: are they a separate category? A monocentric study on 118 patients older than 75 years
Bleeding in essential thrombocythaemia: A retrospective analysis on 565 patients
The CD47 pathway is deregulated in human immune thrombocytopenia
Circulating CD4+CD161+CD196+ Th17 cells are not increased in immune thrombocytopenia
Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: A retrospective study
A novel model of CCl4-induced cirrhosis with ascites in the mouse
Recent advances in the pathology of idiopathic thrombocytopenic purpura
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: Safety of cytoreductive therapy
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia
Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience
Missing publications? Search for publications with a matching author name.